Onsdag 16 September | 10:14:09 Europe / Stockholm
Est. tid*
2026-10-23 09:30 Kvartalsrapport 2026-Q3
2026-08-21 - Kvartalsrapport 2026-Q2
2026-05-05 - X-dag ordinarie utdelning MODU 0.00 EUR
2026-05-04 - Årsstämma
2026-04-24 - Kvartalsrapport 2026-Q1
2026-02-20 - Bokslutskommuniké 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-05 - X-dag ordinarie utdelning MODU 0.00 EUR
2025-05-02 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-21 - Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-06 - X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-20 - 15-10 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02 - Årsstämma
2023-04-28 - 15-10 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02 - Årsstämma
LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består huvudsakligen av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Inside Information: Modulight has received a $1.5 million pilot production order from a U.S. neuroscience customer

2026-09-15 12:25:00

Modulight Corporation | Inside Information | September 15, 2026 at 13:25:00 EEST

Modulight Corporation has received a $1.5 million pilot production purchase order from an existing U.S. venture customer for semiconductor laser products used in a neuroscience application. Modulight has collaborated with the customer for several years to develop laser technology for the application.

Deliveries under the new order will start immediately and are scheduled to continue monthly over the next 12 months. The order represents a transition to pilot production and a significant increase in volumes compared with previous deliveries. The customer has agreed to make prepayments covering all materials required for the ordered products.

The customer develops advanced technology for measuring brain activity and is seeing increasing demand driven by advances in neuroscience and artificial intelligence, as well as their convergence.

“We are very pleased to see our long-term collaboration with this customer progressing to pilot production. Advances in artificial intelligence are creating new possibilities for understanding brain activity, while neuroscience is providing increasingly sophisticated data for AI-based models. This is a field where our specialized laser technology can play an important enabling role,” says Seppo Orsila, CEO of Modulight.